Risankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently published in Rheumatology.
This article was originally published on MedicalXpress.com
Researchers have recently found that several long-lasting human-made contaminants have been building up in Arctic lakes, polar bears and ringed seals and other wildlife. These contaminants belong to a family of chemicals called polyfluoroalkyl and perfluoroalkyl substances (PFAS), […]
Early-onset colorectal cancer incidence among the young, defined as those under age 50, has been rising globally since the early 1990s. Rates for colon and rectal cancers are expected to increase by 90% and 124%, respectively, by 2030. […]
The COVID-19 pandemic has shed light on the precarious living conditions of the elderly in nursing homes in Canada. During the first wave of the pandemic, from March to August 2020, more than 80 per […]
© 2023 SimplyWell.ca